Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Issa

Showing results (171-180 of 209) with videos related to

Pageof 21
Sort By:
Clinical Epigenetics|March 26, 2015
Phase I study of azacitidine and oxaliplatin in patients with advanced cancers that have relapsed or are refractory to any platinum therapyApostolia M Tsimberidou, Rabih Said, Kirk Culotta, et al.
Toxicology and Applied Pharmacology|December 30, 2015
Zebrafish embryos as a screen for DNA methylation modifications after compound exposureManon C Bouwmeester, Sander Ruiter, Tobias Lommelaars, et al.
Cancer|March 15, 2006
Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized studyHagop Kantarjian, Jean-Pierre J Issa, Craig S Rosenfeld, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 23, 2007
Alterations of DNA methylation and histone modifications contribute to gene silencing in hepatocellular carcinomasYutaka Kondo, Lanlan Shen, Seiji Suzuki, et al.
Plos One|August 20, 2011
Frequent alteration of MLL3 frameshift mutations in microsatellite deficient colorectal cancerYoshiyuki Watanabe, Ryan J Castoro, Hyun Soo Kim, et al.
Cancer Research|May 15, 2015
TET2 Mutations Affect Non-CpG Island DNA Methylation at Enhancers and Transcription Factor-Binding Sites in Chronic Myelomonocytic LeukemiaJumpei Yamazaki, Jaroslav Jelinek, Yue Lu, et al.
Carcinogenesis|July 30, 2009
IGFBP7 is a p53-responsive gene specifically silenced in colorectal cancer with CpG island methylator phenotypeHiromu Suzuki, Shinichi Igarashi, Masanori Nojima, et al.
Gastroenterology|November 5, 2013
Hepatitis virus infection affects DNA methylation in mice with humanized liversYasuyuki Okamoto, Keiko Shinjo, Yasuhiro Shimizu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2015
Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF-Mutated Colorectal CancerScott Kopetz, Jayesh Desai, Emily Chan, et al.
Gastroenterology|April 21, 2009
Sensitive and specific detection of early gastric cancer with DNA methylation analysis of gastric washesYoshiyuki Watanabe, Hyun Soo Kim, Ryan J Castoro, et al.
Pageof 21

Showing results (171-180 of 209) with videos related to

Sort By:
Pageof 21
Clinical Epigenetics|March 26, 2015
Phase I study of azacitidine and oxaliplatin in patients with advanced cancers that have relapsed or are refractory to any platinum therapyApostolia M Tsimberidou, Rabih Said, Kirk Culotta, et al.
Toxicology and Applied Pharmacology|December 30, 2015
Zebrafish embryos as a screen for DNA methylation modifications after compound exposureManon C Bouwmeester, Sander Ruiter, Tobias Lommelaars, et al.
Cancer|March 15, 2006
Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized studyHagop Kantarjian, Jean-Pierre J Issa, Craig S Rosenfeld, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 23, 2007
Alterations of DNA methylation and histone modifications contribute to gene silencing in hepatocellular carcinomasYutaka Kondo, Lanlan Shen, Seiji Suzuki, et al.
Plos One|August 20, 2011
Frequent alteration of MLL3 frameshift mutations in microsatellite deficient colorectal cancerYoshiyuki Watanabe, Ryan J Castoro, Hyun Soo Kim, et al.
Cancer Research|May 15, 2015
TET2 Mutations Affect Non-CpG Island DNA Methylation at Enhancers and Transcription Factor-Binding Sites in Chronic Myelomonocytic LeukemiaJumpei Yamazaki, Jaroslav Jelinek, Yue Lu, et al.
Carcinogenesis|July 30, 2009
IGFBP7 is a p53-responsive gene specifically silenced in colorectal cancer with CpG island methylator phenotypeHiromu Suzuki, Shinichi Igarashi, Masanori Nojima, et al.
Gastroenterology|November 5, 2013
Hepatitis virus infection affects DNA methylation in mice with humanized liversYasuyuki Okamoto, Keiko Shinjo, Yasuhiro Shimizu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2015
Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF-Mutated Colorectal CancerScott Kopetz, Jayesh Desai, Emily Chan, et al.
Gastroenterology|April 21, 2009
Sensitive and specific detection of early gastric cancer with DNA methylation analysis of gastric washesYoshiyuki Watanabe, Hyun Soo Kim, Ryan J Castoro, et al.
Pageof 21